Immunostimulatory oligoribonucleotides

Details for Australian Patent Application No. 2011202189 (hide)

Owner Coley Pharmaceutical Group, Inc. Coley Pharmaceutical GmbH

Inventors Forsbach, Alexandra; Vollmer, Joerg; Lipford, Grayson B.

Agent Davies Collison Cave

Pub. Number AU-B-2011202189

Parent 2006318464

Filing date 11 May 2011

Wipo publication date 2 June 2011

Acceptance publication date 17 May 2012

International Classifications

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 31/7105 (2006.01) - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

C12N 15/117 (2010.01) Mutation or genetic engineering - Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

Event Publications

26 May 2011 Complete Application Filed

2 June 2011 Application Open to Public Inspection

  Published as AU-B-2011202189

17 May 2012 Application Accepted

  Published as AU-B-2011202189

13 September 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011202190-Integrated winchhead

2011202188-Method of producing colored highstrength fibers